Jupiter Life Line Hospitals Limited (JLHL.NS)
INR 1444.6
(-0.41%)
INR 1444.6
(-0.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.14 Billion | 1.17 Billion | 1.36 Billion | 1.23 Billion | 487.93 Million |
| Net Income | 1.95 Billion | 1.28 Billion | 771.18 Million | 15.55 Million | 296.33 Million |
| Depreciation & Amortization | 423.82 Million | 385.55 Million | 361.57 Million | 307.37 Million | 259.11 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -809.06 Million | -542.45 Million | -85.99 Million | 631.49 Million | -93.66 Million |
| Other non-cash items | 69.54 Million | 392.07 Million | 419.63 Million | 381.1 Million | 26.15 Million |
| Investing Cash Flow | -758.89 Million | -1.03 Billion | -852.46 Million | -2.95 Billion | -436.59 Million |
| Investments in PPE | -852.95 Million | -772.43 Million | -917.32 Million | -2.41 Billion | -285.93 Million |
| Acquisitions | 13.02 Million | -211.86 Million | -46.04 Million | -569.51 Million | - |
| Investment purchases | -254.92 Million | -119.53 Million | - | - | - |
| Sales/Maturities of investments | 99.11 Million | - | - | - | 3.86 Million |
| Other Investing Activities | 236.85 Million | 3.92 Million | 6.81 Million | 5.64 Million | -154.52 Million |
| Financing Cash Flow | 1.28 Billion | 175 Million | 322.01 Million | 1.84 Billion | -60.52 Million |
| Debt repayment | -4.72 Billion | -308.8 Million | -878.69 Million | -1.53 Billion | -197.96 Million |
| Dividends payments | -56.52 Million | -50.87 Million | - | - | -61.32 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 6.32 Billion | 339.81 Million | 17.88 Million | 499.9 Million | - |
| Other Financing Activities | -263.41 Million | -685.69 Million | -235.2 Million | - | -197.16 Million |
| Accounts receivables | -137.45 Million | - | - | - | -186.81 Million |
| Accounts payables | -84.85 Million | - | - | - | - |
| Inventory | -23.41 Million | -36.45 Million | -23.06 Million | 9.19 Million | -37.6 Million |
| Other working capital | -648.2 Million | - | - | - | 130.75 Million |
| Cash at beginning of period | 1.34 Billion | 1.03 Billion | 184.62 Million | 69.74 Million | 78.92 Million |
| Cash at end of period | 3.01 Billion | 1.34 Billion | 1.03 Billion | 194.38 Million | 69.74 Million |
| Capital Expenditure | -852.95 Million | -772.43 Million | -917.32 Million | -2.41 Billion | -285.93 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.66 Billion | 310.98 Million | 849.03 Million | 124.64 Million | -9.18 Million |
| Free Cash Flow | 292.26 Million | 399.24 Million | 452.4 Million | -1.18 Billion | 202 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 446.05 Million | 452.65 Million | 1.95 Billion | 436.67 Million | 336.83 Million | 539.97 Million |
| Depreciation & Amortization | - | - | 423.82 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -809.06 Million | - | - | - |
| Other non-cash items | -446.05 Million | -452.65 Million | 69.54 Million | -436.67 Million | -336.83 Million | -539.97 Million |
| Investing Cash Flow | - | - | -758.89 Million | - | - | - |
| Investments in PPE | - | - | -852.95 Million | - | - | - |
| Acquisitions | - | - | 13.02 Million | - | - | - |
| Investment purchases | - | - | -254.92 Million | - | - | - |
| Sales/Maturities of investments | - | - | 99.11 Million | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 1.28 Billion | - | - | - |
| Debt repayment | - | - | -4.72 Billion | - | - | - |
| Dividends payments | - | - | -56.52 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 6.32 Billion | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -23.41 Million | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 1.34 Billion | - | - | 1.34 Billion |
| Cash at end of period | - | - | 3.01 Billion | - | - | 1.34 Billion |
| Capital Expenditure | - | - | -852.95 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 1.66 Billion | - | - | - |
| Free Cash Flow | - | - | 292.26 Million | - | - | - |
1033
002926
002620
300735
600822
WXIBF